Hala M Fawzy
Overview
Explore the profile of Hala M Fawzy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
192
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Manie M, Fawzy H, M El-Sayed E
Biol Pharm Bull
. 2024 Jan;
47(1):303-310.
PMID: 38281774
Methotrexate (MTX) is an indispensable drug used for the treatment of many autoimmune and cancerous diseases. However, its clinical use is associated with serious side effects, such as lung fibrosis....
2.
Abdalhameid E, Abd El-Haleim E, Abdelsalam R, Georgy G, Fawzy H, Kenawy S
Naunyn Schmiedebergs Arch Pharmacol
. 2023 Aug;
397(2):1071-1079.
PMID: 37581637
Purpose: Lung fibrosis is a heterogeneous lung condition characterized by excessive accumulation of scarred tissue, leading to lung architecture destruction and restricted ventilation. The current work was conducted to examine...
3.
Fawzy H, Mohammed A, Fawzy H, Fikry E
Can J Physiol Pharmacol
. 2022 Apr;
100(6):542-552.
PMID: 35413206
Acute pancreatitis (AP), a disorder of global importance, has a growing incidence and prevalence, particularly in the Western world. Its complications include pseudocysts and chronic pancreatitis. Pramipexole (PMX), a D2/3...
4.
Mansour H, Fawzy H, El-Khatib A, Khattab M
Neural Regen Res
. 2022 Feb;
17(9):1913-1918.
PMID: 35142667
Numerous molecular mechanisms are being examined in an attempt to discover disease-modifying drugs to slow down the underlying neurodegeneration in Alzheimer's disease. Recent studies have shown the beneficial effects of...
5.
Mansour H, Fawzy H, El-Khatib A, Khattab M
Neurochem Int
. 2021 Sep;
150:105178.
PMID: 34481907
Mitochondrial, autophagic impairment, excitotoxicity, and also neuroinflammation are implicated in Alzheimer's disease (AD) pathophysiology. We postulated that inhibiting the mitochondrial pyruvate carrier-1 (MPC-1), which inhibits the activation of the mammalian...
6.
Mansour H, Fawzy H, El-Khatib A, Khattab M
Neuroscience
. 2021 Jun;
469:191-196.
PMID: 34139302
Clinical trials of new drugs for Alzheimer's disease (AD) have ended with disappointing results, with tremendous resources and time. Repositioning of existing anti-cancer epidermal growth factor receptors (EGFR) inhibitors in...
7.
Mansour H, Fawzy H, El-Khatib A, Khattab M
Exp Neurol
. 2021 Mar;
341:113697.
PMID: 33727095
Epidermal growth factor receptor (EGFR) signaling plays a substantial role in learning and memory. The upregulation of EGFR has been embroiled in the pathophysiology of Alzheimer's disease (AD). Nevertheless, most...
8.
Abdelkader N, Elyamany M, Gad A, Assaf N, Fawzy H, Elesawy W
J Pharmacol Sci
. 2020 Mar;
143(1):23-29.
PMID: 32139333
Valproic acid is a commonly used drug for many psychiatric disorders, particularly for epilepsy. However, it has been reported that its use is associated with possible side effects including hepatotoxicity....
9.
Elfeky M, Mantawy E, Gad A, Fawzy H, El-Demerdash E
Life Sci
. 2019 Nov;
240:117096.
PMID: 31760097
Methods: Male Sprague-Dawley rats were treated with either Con A (20 mg/kg, IV) and/or honokiol (10 mg/kg, orally) for 4 weeks. Hepatotoxicity indices were as well as histopathological evaluation was...
10.
Abdelaziz A, Mantawy E, Gad A, Fawzy H, Azab S
Food Chem Toxicol
. 2019 Jul;
132:110719.
PMID: 31362085
Methotrexate (MTX) is commonly used to treat several types of cancer and autoimmune diseases. However, there is increasing concern over its organs toxicities particularly liver toxicity. Liraglutide, a glucagon like...